CRISPR Therapeutics AG (CRSP)
53.91
+0.18
(+0.34%)
USD |
NASDAQ |
Apr 26, 16:00
53.89
-0.02
(-0.04%)
Pre-Market: 20:00
CRISPR Therapeutics Total Return Price: 53.91 for April 26, 2024
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| April 26, 2024 | 53.91 |
| April 25, 2024 | 53.73 |
| April 24, 2024 | 55.65 |
| April 23, 2024 | 56.41 |
| April 22, 2024 | 55.66 |
| April 19, 2024 | 55.05 |
| April 18, 2024 | 56.16 |
| April 17, 2024 | 55.56 |
| April 16, 2024 | 57.96 |
| April 15, 2024 | 58.72 |
| April 12, 2024 | 60.67 |
| April 11, 2024 | 62.91 |
| April 10, 2024 | 61.74 |
| April 09, 2024 | 65.19 |
| April 08, 2024 | 64.09 |
| April 05, 2024 | 62.90 |
| April 04, 2024 | 65.06 |
| April 03, 2024 | 64.60 |
| April 02, 2024 | 65.03 |
| April 01, 2024 | 68.18 |
| March 28, 2024 | 68.16 |
| March 27, 2024 | 70.16 |
| March 26, 2024 | 70.97 |
| March 25, 2024 | 71.08 |
| March 22, 2024 | 71.61 |
| Date | Value |
|---|---|
| March 21, 2024 | 74.50 |
| March 20, 2024 | 72.94 |
| March 19, 2024 | 71.96 |
| March 18, 2024 | 71.47 |
| March 15, 2024 | 72.95 |
| March 14, 2024 | 72.01 |
| March 13, 2024 | 74.78 |
| March 12, 2024 | 75.30 |
| March 11, 2024 | 76.82 |
| March 08, 2024 | 78.92 |
| March 07, 2024 | 79.37 |
| March 06, 2024 | 80.83 |
| March 05, 2024 | 80.99 |
| March 04, 2024 | 81.74 |
| March 01, 2024 | 83.75 |
| February 29, 2024 | 84.22 |
| February 28, 2024 | 87.68 |
| February 27, 2024 | 89.12 |
| February 26, 2024 | 86.06 |
| February 23, 2024 | 83.99 |
| February 22, 2024 | 86.19 |
| February 21, 2024 | 82.41 |
| February 20, 2024 | 78.73 |
| February 16, 2024 | 82.22 |
| February 15, 2024 | 84.48 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
33.68
Minimum
Mar 16 2020
210.04
Maximum
Jan 14 2021
74.11
Average
63.26
Median
Jun 09 2020
Total Return Price Benchmarks
| Vertex Pharmaceuticals Inc | 397.48 |
| Intellia Therapeutics Inc | 20.76 |
| Novartis AG | 97.44 |
| Verve Therapeutics Inc | 6.16 |
| AC Immune SA | 2.35 |